Literature DB >> 28258686

Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury.

Theo P Menting1, Kimberley E Wever1, Denise Md Ozdemir-van Brunschot1, Daan Ja Van der Vliet1, Maroeska M Rovers2, Michiel C Warle1.   

Abstract

BACKGROUND: Ischaemia reperfusion injury can lead to kidney dysfunction or failure. Ischaemic preconditioning is a short period of deprivation of blood supply to particular organs or tissue, followed by a period of reperfusion. It has the potential to protect kidneys from ischaemia reperfusion injury.
OBJECTIVES: This review aimed to look at the benefits and harms of local and remote ischaemic preconditioning to reduce ischaemia and reperfusion injury among people with renal ischaemia reperfusion injury. SEARCH
METHODS: We searched Cochrane Kidney and Transplant's Specialised Register to 5 August 2016 through contact with the Information Specialist using search terms relevant to this review. SELECTION CRITERIA: We included all randomised controlled trials measuring kidney function and the role of ischaemic preconditioning in patients undergoing a surgical intervention that induces kidney injury. Kidney transplantation studies were excluded. DATA COLLECTION AND ANALYSIS: Studies were assessed for eligibility and quality; data were extracted by two independent authors. We collected basic study characteristics: type of surgery, remote ischaemic preconditioning protocol, type of anaesthesia. We collected primary outcome measurements: serum creatinine and adverse effects to remote ischaemic preconditioning and secondary outcome measurements: acute kidney injury, need for dialysis, neutrophil gelatinase-associated lipocalin, hospital stay and mortality. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios (RR) and their 95% confidence intervals (CI) for dichotomous outcomes, and mean difference (MD) and 95% CI for continuous outcomes. MAIN
RESULTS: We included 28 studies which randomised a total of 6851 patients. Risk of bias assessment indicated unclear to low risk of bias for most studies. For consistency regarding the direction of effects, continuous outcomes with negative values, and dichotomous outcomes with values less than one favour remote ischaemic preconditioning. Based on high quality evidence, remote ischaemic preconditioning made little or no difference to the reduction of serum creatinine levels at postoperative days one (14 studies, 1022 participants: MD -0.02 mg/dL, 95% CI -0.05 to 0.02; I2 = 21%), two (9 studies, 770 participants: MD -0.04 mg/dL, 95% CI -0.09 to 0.02; I2 = 31%), and three (6 studies, 417 participants: MD -0.05 mg/dL, 95% CI -0.19 to 0.10; I2 = 68%) compared to control.Serious adverse events occurred in four patients receiving remote ischaemic preconditioning by iliac clamping. It is uncertain whether remote ischaemic preconditioning by cuff inflation leads to increased adverse effects compared to control because the certainty of the evidence is low (15 studies, 3993 participants: RR 3.47, 95% CI 0.55 to 21.76; I2 = 0%); only two of 15 studies reported any adverse effects (6/1999 in the remote ischaemic preconditioning group and 1/1994 in the control group), the remaining 13 studies stated no adverse effects were observed in either group.Compared to control, remote ischaemic preconditioning made little or no difference to the need for dialysis (13 studies, 2417 participants: RR 0.85, 95% CI 0.37 to 1.94; I2 = 60%; moderate quality evidence), length of hospital stay (8 studies, 920 participants: MD 0.17 days, 95% CI -0.46 to 0.80; I2 = 49%, high quality evidence), or all-cause mortality (24 studies, 4931 participants: RR 0.86, 95% CI 0.54 to 1.37; I2 = 0%, high quality evidence).Remote ischaemic preconditioning may have slightly improved the incidence of acute kidney injury using either the AKIN (8 studies, 2364 participants: RR 0.76, 95% CI 0.57 to 1.00; I2 = 61%, high quality evidence) or RIFLE criteria (3 studies, 1586 participants: RR 0.91, 95% CI 0.75 to 1.12; I2 = 0%, moderate quality evidence). AUTHORS'
CONCLUSIONS: Remote ischaemic preconditioning by cuff inflation appears to be a safe method, and probably leads to little or no difference in serum creatinine, adverse effects, need for dialysis, length of hospital stay, death and in the incidence of acute kidney injury. Overall we had moderate-high certainty evidence however the available data does not confirm the efficacy of remote ischaemic preconditioning in reducing renal ischaemia reperfusion injury in patients undergoing major cardiac and vascular surgery in which renal ischaemia reperfusion injury may occur.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28258686      PMCID: PMC6464274          DOI: 10.1002/14651858.CD010777.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  93 in total

1.  Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial.

Authors:  Yong Seon Choi; Jae Kwang Shim; Jong Chan Kim; Kyu-Sik Kang; Yong Han Seo; Ki-Ryang Ahn; Young Lan Kwak
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01-26       Impact factor: 5.209

2.  [Protective effects of ischemic preconditioning on myocardium during patients undergoing heart valve replacement surgery].

Authors:  G Li; S Chen; E Lu
Journal:  Hunan Yi Ke Da Xue Xue Bao       Date:  1999

3.  Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery--randomized controlled trial.

Authors:  Deok Man Hong; Yunseok Jeon; Chang-Soon Lee; Hyun Joo Kim; Jung-Man Lee; Jae-Hyon Bahk; Ki-Bong Kim; Ho Young Hwang
Journal:  Circ J       Date:  2012-02-03       Impact factor: 2.993

4.  A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery.

Authors:  Patrick Meybohm; Berthold Bein; Oana Brosteanu; Jochen Cremer; Matthias Gruenewald; Christian Stoppe; Mark Coburn; Gereon Schaelte; Andreas Böning; Bernd Niemann; Jan Roesner; Frank Kletzin; Ulrich Strouhal; Christian Reyher; Rita Laufenberg-Feldmann; Marion Ferner; Ivo F Brandes; Martin Bauer; Sebastian N Stehr; Andreas Kortgen; Maria Wittmann; Georg Baumgarten; Tanja Meyer-Treschan; Peter Kienbaum; Matthias Heringlake; Julika Schön; Michael Sander; Sascha Treskatsch; Thorsten Smul; Ewa Wolwender; Thomas Schilling; Georg Fuernau; Dirk Hasenclever; Kai Zacharowski
Journal:  N Engl J Med       Date:  2015-10-05       Impact factor: 91.245

5.  Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: a randomized controlled trial.

Authors:  Stewart R Walsh; Jonathan R Boyle; Tjun Y Tang; Umar Sadat; David G Cooper; Marta Lapsley; Anthony G Norden; Kevin Varty; Paul D Hayes; Michael E Gaunt
Journal:  J Endovasc Ther       Date:  2009-12       Impact factor: 3.487

6.  Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.

Authors:  Matthias Thielmann; Eva Kottenberg; Kerstin Boengler; Christoph Raffelsieper; Markus Neuhaeuser; Jürgen Peters; Heinz Jakob; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2010-05-21       Impact factor: 17.165

7.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

8.  Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.

Authors:  E Kottenberg; M Thielmann; P Kleinbongard; U H Frey; T Heine; H Jakob; G Heusch; J Peters
Journal:  Acta Anaesthesiol Scand       Date:  2014-02-18       Impact factor: 2.105

9.  Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.

Authors:  Astrid D Sloth; Michael R Schmidt; Kim Munk; Rajesh K Kharbanda; Andrew N Redington; Morten Schmidt; Lars Pedersen; Henrik T Sørensen; Hans Erik Bøtker
Journal:  Eur Heart J       Date:  2013-09-12       Impact factor: 29.983

10.  Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single-center double-blinded randomized trial.

Authors:  Brian W McCrindle; Nadia A Clarizia; Svetlana Khaikin; Helen M Holtby; Cedric Manlhiot; Steven M Schwartz; Christopher A Caldarone; John G Coles; Glen S Van Arsdell; Stephen W Scherer; Andrew N Redington
Journal:  J Am Heart Assoc       Date:  2014-07-28       Impact factor: 5.501

View more
  17 in total

Review 1.  Effects of remote ischemic preconditioning on liver injury following hepatectomy: a systematic review and meta-analysis of randomized control trials.

Authors:  Hao Zhang; Ting Zhang; Furui Zhong; Xianming Xia
Journal:  Surg Today       Date:  2021-01-19       Impact factor: 2.549

Review 2.  [Prevention of acute kidney injury in critically ill patients : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  M Joannidis; S J Klein; S John; M Schmitz; D Czock; W Druml; A Jörres; D Kindgen-Milles; J T Kielstein; M Oppert; V Schwenger; C Willam; A Zarbock
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-28       Impact factor: 0.840

3.  Assessing renal changes after remote ischemic preconditioning (RIPC) of the upper extremity using BOLD imaging at 3T.

Authors:  Florian Siedek; Thorsten Persigehl; Roman-Ulrich Mueller; Volker Burst; Thomas Benzing; David Maintz; Stefan Haneder
Journal:  MAGMA       Date:  2017-10-23       Impact factor: 2.310

Review 4.  Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury.

Authors:  Theo P Menting; Kimberley E Wever; Denise Md Ozdemir-van Brunschot; Daan Ja Van der Vliet; Maroeska M Rovers; Michiel C Warle
Journal:  Cochrane Database Syst Rev       Date:  2017-03-04

5.  Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Authors:  Jiajun Dong; Mingyang Cao; Hui Yu; Yang Dong; Conghui Han
Journal:  Ann Transplant       Date:  2022-09-30       Impact factor: 1.479

Review 6.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

7.  Determination of a microRNA signature of protective kidney ischemic preconditioning originating from proximal tubules.

Authors:  Usman Khalid; Robert H Jenkins; Robert Andrews; Gilda Pino-Chavez; Benjamin C Cossins; Rafael Chavez; Timothy Bowen; Donald J Fraser
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

Review 8.  Remote ischaemic conditioning for preventing and treating ischaemic stroke.

Authors:  Wenbo Zhao; Jing Zhang; Mordechai G Sadowsky; Ran Meng; Yuchuan Ding; Xunming Ji
Journal:  Cochrane Database Syst Rev       Date:  2018-07-05

Review 9.  Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group.

Authors:  Mitra K Nadim; Lui G Forni; Azra Bihorac; Charles Hobson; Jay L Koyner; Andrew Shaw; George J Arnaoutakis; Xiaoqiang Ding; Daniel T Engelman; Hrvoje Gasparovic; Vladimir Gasparovic; Charles A Herzog; Kianoush Kashani; Nevin Katz; Kathleen D Liu; Ravindra L Mehta; Marlies Ostermann; Neesh Pannu; Peter Pickkers; Susanna Price; Zaccaria Ricci; Jeffrey B Rich; Lokeswara R Sajja; Fred A Weaver; Alexander Zarbock; Claudio Ronco; John A Kellum
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501

Review 10.  Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.

Authors:  M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz
Journal:  Intensive Care Med       Date:  2017-06-02       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.